JPMorgan Chase & Co. Has $123.80 Million Stock Position in Xylem Inc. $XYL

JPMorgan Chase & Co. lowered its stake in Xylem Inc. (NYSE:XYL) by 20.5% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 839,259 shares of the industrial products company’s stock after selling 216,244 shares during the quarter. JPMorgan Chase & Co. owned approximately 0.34% of Xylem worth $123,799,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds also recently bought and sold shares of XYL. State of Wyoming boosted its holdings in shares of Xylem by 10.4% in the third quarter. State of Wyoming now owns 756 shares of the industrial products company’s stock worth $112,000 after buying an additional 71 shares during the period. Private Trust Co. NA boosted its stake in Xylem by 22.4% in the 3rd quarter. Private Trust Co. NA now owns 459 shares of the industrial products company’s stock worth $68,000 after purchasing an additional 84 shares during the period. Ascent Wealth Partners LLC grew its position in Xylem by 0.6% during the 3rd quarter. Ascent Wealth Partners LLC now owns 14,385 shares of the industrial products company’s stock worth $2,122,000 after purchasing an additional 87 shares in the last quarter. Courier Capital LLC raised its stake in Xylem by 4.8% during the 3rd quarter. Courier Capital LLC now owns 1,989 shares of the industrial products company’s stock valued at $293,000 after purchasing an additional 91 shares during the period. Finally, Apollon Wealth Management LLC lifted its holdings in shares of Xylem by 0.5% in the third quarter. Apollon Wealth Management LLC now owns 17,913 shares of the industrial products company’s stock valued at $2,642,000 after purchasing an additional 92 shares in the last quarter. 87.96% of the stock is owned by hedge funds and other institutional investors.

Xylem Price Performance

NYSE XYL opened at $128.59 on Monday. The company has a quick ratio of 1.28, a current ratio of 1.62 and a debt-to-equity ratio of 0.12. The stock has a market capitalization of $31.31 billion, a PE ratio of 32.80, a price-to-earnings-growth ratio of 1.84 and a beta of 1.17. Xylem Inc. has a 12-month low of $100.47 and a 12-month high of $154.27. The company has a 50 day moving average price of $137.53 and a two-hundred day moving average price of $141.60.

Xylem (NYSE:XYL) last released its quarterly earnings results on Tuesday, February 10th. The industrial products company reported $1.42 earnings per share for the quarter, meeting analysts’ consensus estimates of $1.42. The business had revenue of $2.40 billion for the quarter, compared to the consensus estimate of $2.37 billion. Xylem had a net margin of 10.59% and a return on equity of 11.11%. Xylem’s revenue for the quarter was up 6.3% on a year-over-year basis. During the same quarter last year, the firm earned $1.18 EPS. Xylem has set its FY 2026 guidance at 5.350-5.560 EPS. As a group, equities analysts predict that Xylem Inc. will post 4.65 earnings per share for the current fiscal year.

Xylem Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, March 24th. Stockholders of record on Tuesday, February 24th will be paid a dividend of $0.43 per share. This is a boost from Xylem’s previous quarterly dividend of $0.40. The ex-dividend date is Tuesday, February 24th. This represents a $1.72 annualized dividend and a dividend yield of 1.3%. Xylem’s dividend payout ratio is currently 40.82%.

Analyst Upgrades and Downgrades

XYL has been the topic of a number of research analyst reports. UBS Group reiterated a “buy” rating and set a $155.00 price target on shares of Xylem in a report on Friday, February 13th. Weiss Ratings reiterated a “buy (b-)” rating on shares of Xylem in a report on Monday, December 29th. Citigroup reduced their price target on shares of Xylem from $182.00 to $174.00 and set a “buy” rating for the company in a research report on Wednesday, February 11th. Wall Street Zen downgraded shares of Xylem from a “buy” rating to a “hold” rating in a research report on Saturday, December 27th. Finally, Robert W. Baird set a $161.00 price objective on shares of Xylem in a research note on Wednesday, February 11th. Nine analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. According to data from MarketBeat, Xylem has an average rating of “Moderate Buy” and an average price target of $158.08.

Xylem Profile

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.